Masimo
Masimo Corporation, founded in 1989 and headquartered in Irvine, California, is a medical technology company that develops, manufactures, and markets innovative non-invasive patient monitoring measurements, sensors and devices, hospital automation and connectivity solutions, telehealth solutions, and consumer health and wellness devices. Masimo is best known for its pulse oximetry technology, Masimo Signal Extraction Technology® (SET®) — which today is considered to be modern pulse oximetry. Masimo SET® addresses the limitations of conventional pulse oximetry, such as its poor performance during patient motion or low perfusion. Founder and CEO Joe Kiani was inspired to develop more reliable, accurate technology after observing ineffective pulse oximetry in the neonatal care unit (NICU). Masimo’s pulse oximetry is at the heart of many of its monitoring devices and products. In 2023, SET®’s origin — as a way to more reliably monitor NICU babies — came full circle with the introduction of Masimo Stork™, a baby monitor that uses SET® and other advanced technologies to help parents track their babies’ health indicators at home. In addition to Masimo SET®, the company has developed numerous noninvasive measurements (collectively known as the rainbow SET® family of measurements), a suite of advanced devices like the Root® patient monitoring and connectivity platform, many other innovative bedside, handheld, and tetherless devices, and remote patient monitoring and management solutions like Masimo Patient SafetyNet™ and Masimo SafetyNet These devices and solutions help caregivers monitor numerous physiological parameters including blood oxygen saturation (SET® SpO2), total hemoglobin (SpHb®) carboxyhemoglobin (SpCO®), fluid responsiveness (PVi®), methemoglobin (SpMet), respiration rate from the pleth (RRp®), brain function while sedated (SedLine®), regional and cerebral oximetry (O3®), cardiac output (LiDCO™), end-tidal carbon dioxide and other capnography measurements (NomoLine®), acoustic respiratory rate (RRa®), and more. Masimo also develops therapeutic products like Masimo softFlow™ which delivers respiratory support to patients with spontaneous breathing. Additionally, Bridge™ by Masimo is a non-drug device that alleviates symptoms of opioid withdrawal through neuromodulation — making recovery safer and easier. Masimo also offers the first FDA-authorized device to alert users in the event of an opioid overdose, Opioid Halo™, and wearable devices like the Masimo W1™ advanced health tracking watch. The company sells its products to end-users through direct sales and distributors, as well as to original equipment manufacturers (OEMs) and other partners to incorporate into their products.
LiDCO is a supplier of non-invasive and minimally invasive hemodynamic equipment used to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. Clinical studies show that optimising the hemodynamic status of high risk patients produces better outcomes and reduced hospital stay. Since launching our first product in 1999, LiDCO has been committed to improving patient outcomes whilst providing excellent customer service. Dedicated to making a difference.
TNI medical develops, produces, and markets diagnostic and therapeutic equipment in the field of respiratory assistance therapy. Its TNI SoftFlow System maximizes patient comfort with full respiratory support. TNI medical offers its products through its sites in Würzburg, Dessau, and Baltimore. It began operation in 2007, with its headquarters in Freiburg in Germany.
StartUp Health is investing in a global army of Health Transformers to achieve health moonshots. StartUp Health is on a 30-year mission to collaborate with entrepreneurs to improve the health and wellbeing of everyone in the world. Since 2011, StartUp Health has been investing in a global army of entrepreneurs -- called Health Transformers -- to achieve health moonshots: Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. StartUp Health has the world’s largest health innovation portfolio with more than 330 companies across six continents and 26 countries and is backed by leading investors including Advocate Aurora Health, Chiesi, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, GuideWell, Jason Finger, Jerry Levin, Kaiser Permanente, Masimo, Novartis, Otsuka, and Ping An.
Spire Corporation engages in the development, manufacture, and marketing of engineered products and services in the areas of PV solar, biomedical, and optoelectronics. The company offers specialized equipment for the production of terrestrial photovoltaic modules from solar cells. It also provides surface treatments to manufacturers of orthopedic and other medical devices; develops and markets coated and uncoated hemodialysis catheters and related devices for the treatment of chronic kidney disease; and performs sponsored research programs into practical applications of advanced biomedical and biophotonic technologies. In addition, the company offers custom compound semiconductor foundry and fabrication services to customers involved in biomedical/biophotonic instruments, telecommunications, and defense applications. It also involves in compound semiconductor wafer growth, thin film and related device processing, and fabrication services. Further, Spire Corporation provides materials testing services, as well as offers services in support of sponsored research into practical applications of optoelectronic technologies. It sells its products and services primarily through its independent sales representatives and distributors, as well as grants licenses to third parties to sell its products in the United States, Europe, north Africa, Asia, and rest of the world. The company was founded in 1969 and is headquartered in Bedford, Massachusetts.
SEDLine, Inc. is a research-focused company with the mission to expand the scope and applications for neuromonitoring. Based on over 10 years of technical and clinical development, the SEDLine core product is a pioneering four-channel brain-function monitor that measures the effects of anesthesia and sedation by simultaneously analyzing, quantifying and displaying both sides of the brain's electrical activity. The SEDLine monitor is currently in use at some of the nation's leading healthcare institutions. Privately held and based in Irvine, California, SEDLine has an active R&D effort underway to develop advanced brain function monitoring technologies for next generation monitors to further improve the care of patients under anesthesia or sedation.
SEDLine, Inc. is a research-focused company with the mission to expand the scope and applications for neuromonitoring. Based on over 10 years of technical and clinical development, the SEDLine core product is a pioneering four-channel brain-function monitor that measures the effects of anesthesia and sedation by simultaneously analyzing, quantifying and displaying both sides of the brain's electrical activity. The SEDLine monitor is currently in use at some of the nation's leading healthcare institutions. Privately held and based in Irvine, California, SEDLine has an active R&D effort underway to develop advanced brain function monitoring technologies for next generation monitors to further improve the care of patients under anesthesia or sedation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.